Next 10 |
home / stock / lsl:cc / lsl:cc news
BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered priva...
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholder...
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has met the closing conditions of a non-brokered private placement for $1,5 million represent...
BOUCHERVILLE, Québec, June 18, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé ("Virage"), a company specializing in the...
BOUCHERVILLE, Quebec, June 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, announces that, subject to regulatory approval, it has retained, effective June 10, 2024, Red Cloud Securit...
Up to $3.0 M in cash proceeds Up to $1.5 M in debts conversion BOUCHERVILLE, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the launch of a ...
Record Revenues of $4.2 million in Q1-24 up 106% over Q1-23 Record Adjusted Gross margins for Q1-24 of $1.6 million up 141% over Q1-23 Operating profits of $0.2 million for Q1-24 compared to a loss of $0.3 million for Q1-23 $0.65 million Adjusted EBITDA profit for Q1-24, up $0.65 mill...
BOUCHERVILLE, Quebec, May 22, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce that the Convertible Unsecured Redeemable Debentures (the "Debentures") issued pursua...
Transaction expected to increase annual revenues by 15-20% Acquisition to boost overall profitability Transaction expected to close by end of Q2-24 BOUCHERVILLE, Québec, May 06, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LS...
FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase. Gross margins for FY-2023 up $3.8 million compared to FY-2022 Net loss for FY-2023 of $8.5 million compared to $8.1 million for FY-2022 Q4-2023 Revenues of $3.5 million, u...
News, Short Squeeze, Breakout and More Instantly...
Bunker Hill Mining Corp. Company Name:
LSL:CC Stock Symbol:
CNQC Market:
BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered priva...
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholder...
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has met the closing conditions of a non-brokered private placement for $1,5 million represent...